

Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
2022-08-18 | NDAQ:BCRX | Press Release | BioCryst Pharmaceuticals Inc. | stockhouse.com • |
Russell Investments Group Ltd. Has $1.31 Million Position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) | defenseworld.net • |
BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading | investorsobserver.com • |
Ginkgo Bioworks Holdings Inc (DNA) Down 3.48% in Premarket Trading | investorsobserver.com • |
BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia | marketscreener.com • |
State Board of Administration of Florida Retirement System Sells 13040 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) | defenseworld.net • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2022-08-04 | 2022-06 | -0.36 | -0.32 | 0.04 | 11.11% |
2022-05-05 | 2022-03 | -0.39 | -0.4 | -0.01 | -2.56% |
2022-02-23 | 2021-12 | -0.31 | -0.4 | -0.09 | -29.03% |
2021-11-03 | 2021-09 | -0.3 | -0.33 | -0.03 | -10.00% |
2021-08-05 | 2021-06 | -0.22 | -0.24 | -0.02 | -9.09% |
2021-05-06 | 2021-03 | -0.26 | -0.36 | -0.1 | -38.46% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2022-08-08 | Oppenheimer | Downgrade | Outperform | Perform |
2022-08-05 | Barclays | Upgrade | Equal-Weight | |
2022-08-05 | Oppenheimer | Downgrade | Outperform | Perform |
2022-08-05 | Evercore ISI Group | Downgrade | Outperform | In-Line |
2022-04-18 | Barclays | Downgrade | Overweight | Equal-Weight |
2022-04-12 | RBC Capital | Upgrade | Sector Perform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-06-06 | ABERCROMBIE GEORGE B | Director | 12.87K | Stock Award(Grant) |
2022-06-06 | ASELAGE STEPHEN J | Director | 46.59K | Stock Award(Grant) |
2022-06-06 | GALSON STEVEN K | Director | 12.87K | Stock Award(Grant) |
2022-06-06 | HEGGIE THERESA | Director | 30.23K | Stock Award(Grant) |
2022-06-06 | HUTSON NANCY J | Director | 77.94K | Stock Award(Grant) |
2022-06-06 | INGRAM ROBERT ALEXANDER | Director | 95.00K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-06-29 | Blackrock Inc. | 13.99M | 199.32M | 7.52% |
2022-06-29 | Vanguard Group, Inc. (The) | 13.81M | 196.79M | 7.43% |
2022-03-30 | Baker Brothers Advisors, LLC | 12.71M | 181.13M | 6.84% |
2022-03-30 | State Street Corporation | 7.46M | 106.34M | 4.01% |
2022-06-29 | Pictet Asset Management SA | 6.05M | 86.17M | 3.25% |
2022-06-29 | Fisher Asset Management, LLC | 5.22M | 74.34M | 2.81% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2022-06-29 | SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 7.26M | 103.50M | 3.91% |
2022-03-30 | Vanguard Total Stock Market Index Fund | 5.26M | 74.97M | 2.83% |
2022-06-29 | iShares Russell 2000 ETF | 4.17M | 59.43M | 2.25% |
2022-05-30 | Fidelity Select Portfolios - Biotechnology | 4.19M | 59.74M | 2.25% |
2022-04-29 | Lord Abbett Developing Growth Fund | 2.45M | 34.94M | 1.32% |
2022-03-30 | Vanguard Extended Market Index Fund | 2.39M | 34.03M | 1.29% |
Dividend | Date |
---|---|
0 | 2014-06-11 |
0 | 2014-06-05 |
0 | 2014-05-20 |
0 | 2014-05-16 |
0 | 2014-04-02 |
-
$BCRX I sure hope @Imakook gives us some direction today
-
$BCRX I had 31K shares sitting right here a few day’s ago…does this concern any of you?
-
-
$BCRX Great we’ve got Imacouk sharing knowledge this morning it’s gona be a good day?
-
$BCRX Where is this guy mike smith getting subway sandwiches for $4.00 in Dallas there all $5.50.
-
$BCRX Well since my account is going to hell in a hand basket and my family relies on me I’m going to go to my beach house for the week and think about it………now what was I thinking about? Heaven help us all.
-
$BCRX $4.67 how wet it is!
-
$BCRX Wow Mikey this thing is gona take off …run and tell your mommy
-
$BCRX I needed a smile…thanks
-
$BCRX
Who’s it gonna bbbe -
$BCRX Let my people go you raskley rats
-
$BCRX BINGO
-
$BCRX Creatine levels are leveling out …good news
-
‘$BCRX I’m glad to see someone else is concerned about something not just the Sea Turd
-
$BCRX @Harrington with all the trash you spout this is about as far as your going to get buddy
-
$BCRX I think it’s time
-
$BCRX BASTARDS BASTARDS BASTARDS……….
-
$BCRX So much for that 1k share add at “this is going to be the bottom” price of 9.97.
-
$BCRX You ever felt like you’ve been stabbed in the back…just wondering?
-
BioCryst Pharmaceuticals Inc (BCRX) Down 3.35% in Premarket Trading
investorsobserver.com • -
Ginkgo Bioworks Holdings Inc (DNA) Down 3.48% in Premarket Trading
investorsobserver.com • -
BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia
marketscreener.com • -
Top 5 2nd Quarter Trades of Biondo Investment Advisors, LLC
gurufocus.com • -
Options Bulls Blast Phama Stock on Lifted Clinical Hold
schaeffersresearch.com • -
3 Fast-Growing Stocks to Buy Now
fool.com • -
BioCryst to Report Second Quarter 2022 Financial Results on August 4
globenewswire.com • -
BioCryst to Present at Upcoming Investor Conference
globenewswire.com • -
BioCryst: A Prudent Diversification
seekingalpha.com • -
7 Cheap Biotech Stocks to Buy Now
investorplace.com • -
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com • -
BioCryst to Report First Quarter 2022 Financial Results on May 5
globenewswire.com • -
Why BioCryst Pharmaceuticals Stock Is Falling
benzinga.com • -
BioCryst to Present at Upcoming Investor Conference
globenewswire.com • -
Why BioCryst Pharmaceuticals Stock Is Plunging Today
benzinga.com • -
BioCryst Provides Tremendous Option Value
seekingalpha.com • -
BioCryst: Great Execution, Impressive Pipeline, Long Cash Runway
seekingalpha.com • -
7 Top Growth Stocks to Buy as We Step Into November
investorplace.com • -
BioCryst to Report Third Quarter 2021 Financial Results on November 3
globenewswire.com • -
7 Best Growth Stocks to Buy and Hold for the Next 10 Years
investorplace.com • -
2 Super-Charged Growth Stocks to Buy Now
fool.com • -
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com • -
NICE Recommends BioCryst's Hereditary Angioedema Med
benzinga.com • -
What Wall Street Still Has Wrong. BioCryst To Become Next Rare Disease Giant
seekingalpha.com • -
BioCryst to Present at Upcoming Investor Conferences
globenewswire.com • -
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com • -
BioCryst Appoints Dr. Steven Galson to Board of Directors
globenewswire.com • -
BioCryst Stock Jumps After Pulling Out $200M Equity Raise
benzinga.com • -
BioCryst Withdraws Public Offering
globenewswire.com • -
BioCryst Pharma Stock Heads Higher Thursday: Here's Why
benzinga.com • -
3 Biotech Stocks That Could Rocket Higher
fool.com • -
BioCryst to Report Second Quarter 2021 Financial Results on August 5
globenewswire.com • -
BioCryst Pharmaceuticals - Orladeyo Revenue Will Drive Share Price
seekingalpha.com • -
7 A-Rated Biotech Stocks to Buy Now
investorplace.com • -
BioCryst Pharmaceuticals: An Orphan Disease Innovator With More Upside
seekingalpha.com • -
Is BioCryst a Good Stock to Buy Now?
fool.com • -
BioCryst: Solid Delivery And Follow Through
seekingalpha.com • -
BioCryst to Present at 20th Annual Needham Virtual Healthcare Conference
globenewswire.com • -
BCRX Stock Price: $15 Target By Piper Sandler
pulse2.com • -
BioCryst Technical Levels To Watch
benzinga.com •